LITERATURE-BASED META-ANALYSIS TO EVALUATE THE SURROGACY OF PROGRESSION-FREE SURVIVAL IN GLIOBLASTOMA MULTIFORM

被引：0
|
作者：
Ren, M. M. [1 ]
Han, K. [1 ]
Li, J. [1 ]
Su, Z. [1 ]
Das, A. [1 ]
Joshi, A. [1 ]
Jin, J. Y. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [1] Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
    Han, Kelong
    Ren, Melanie
    Wick, Wolfgang
    Abrey, Lauren
    Das, Asha
    Jin, Jin
    Reardon, David A.
    NEURO-ONCOLOGY, 2014, 16 (05) : 696 - 706
  • [2] Surrogacy of progression-free survival (PFS) for overall survival (OS) in esophageal cancer trials with preoperative therapy: Literature-based meta-analysis
    Kataoka, K.
    Nakamura, K.
    Mizusawa, J.
    Kato, K.
    Eba, J.
    Katayama, H.
    Shibata, T.
    Fukuda, H.
    EJSO, 2017, 43 (10): : 1956 - 1961
  • [3] Progression-free survival as a surrogate endpoint for hazard ratio and median overall survival in glioblastoma: A literature-based meta-analysis from 91 trials
    Han, K.
    Ren, M.
    Wick, W.
    Jin, J.
    Abrey, L.
    Das, A.
    Reardon, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S775 - S776
  • [4] Surrogacy of progression-free survival (PFS) for overall survival (OS) in rectal cancer trials with preoperative therapy: Literature-based meta-analysis.
    Mizusawa, Junki
    Nakamura, Kenichi
    Kataoka, Kozo
    Eba, Junko
    Katayama, Hiroshi
    Shibata, Taro
    Fukuda, Haruhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [5] Surrogacy of progression-free survival (PFS) for overall survival (OS) in esophageal cancer (EC) trials with preoperative therapy (PreTx): Literature-based meta-analysis.
    Kataoka, Kozo
    Nakamura, Kenichi
    Mizusawa, Junki
    Eba, Junko
    Katayama, Hiroshi
    Kato, Ken
    Shibata, Taro
    Fukuda, Haruhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [6] Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma
    Han, Kelong
    Ren, Melanie
    Wick, Wolfgang
    Abrey, Lauren
    Das, Asha
    Jin, Jin
    Reardon, David A.
    NEURO-ONCOLOGY, 2015, 17 (05) : 764 - 765
  • [7] Relationship between progression-free survival and overall survival in chronic lymphocytic leukemia: a literature-based analysis
    Beauchemin, C.
    Johnston, J. B.
    Lapierre, M. E.
    Aissa, F.
    Lachaine, J.
    CURRENT ONCOLOGY, 2015, 22 (03) : E148 - E156
  • [8] Concordance index: Surrogacy of progression-free survival for overall survival
    Fan, Yiwei
    Yin, Guosheng
    CONTEMPORARY CLINICAL TRIALS, 2021, 104
  • [9] Potential Surrogate Endpoints for Progression-Free Survival (PFS) and Overall Survival (OS) in Non-Hodgkin Lymphoma: A Literature-Based Meta-analysis of Phase II and Phase III Studies
    Zhu, Rui
    Lu, Dan
    Chu, Wayne
    Chai, Akiko
    Green, Michelle
    Zhang, Nancy
    Jin, Jin Yan
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S78 - S78
  • [10] EFFECTS OF METFORMIN USE ON PROGRESSION-FREE AND OVERALL SURVIVAL OF GLIOBLASTOMA CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Menon, S. S.
    Yadav, N.
    Yeddala, S. P.
    Doucette, J.
    Harris, C.
    Murimi-Worstell, I. B.
    VALUE IN HEALTH, 2021, 24 : S19 - S20
12345